A first-in-class small-molecule inhibitor targeting AVIL exhibits safety and antitumor efficacy in preclinical models of glioblastoma

ABSTRACT: Compound A or DMSO treatment with GBM U87 cell samples

ORGANISM(S): Homo sapiens

PROVIDER: GSE268857 | GEO | 2025/11/18

REPOSITORIES: GEO